Plasma levels of soluble amyloid precursor protein ? in symptomatic Alzheimer's disease.

Alexopoulos, Panagiotis; Gleixner, Lena-Sophie; Werle, Lukas; Buhl, Felix; Thierjung, Nathalie; Giourou, Evangelia; Kagerbauer, Simone M; Gourzis, Philippos; Kübler, Hubert; Grimmer, Timo; Yakushev, Igor; Martin, Jan; Kurz, Alexander; Perneczky, Robert

doi:10.1007/s00406-017-0815-9

2018

Zurück
Zurück zum Anfang der Trefferliste
Dauerhafter Link zum angezeigten Objekt

Dokumenttyp:: Journal Article
Autor(en):: Alexopoulos, Panagiotis; Gleixner, Lena-Sophie; Werle, Lukas; Buhl, Felix; Thierjung, Nathalie; Giourou, Evangelia; Kagerbauer, Simone M; Gourzis, Philippos; Kübler, Hubert; Grimmer, Timo; Yakushev, Igor; Martin, Jan; Kurz, Alexander; Perneczky, Robert
Titel:: Plasma levels of soluble amyloid precursor protein ? in symptomatic Alzheimer's disease.
Abstract:: The established biomarkers of Alzheimer's disease (AD) require invasive endeavours or presuppose sophisticated technical equipment. Consequently, new biomarkers are needed. Here, we report that plasma levels of soluble amyloid precursor protein ? (sAPP?), a protein of the initial phase of the amyloid cascade, were significantly lower in patients with symptomatic AD (21 with mild cognitive impairment due to AD and 44 with AD dementia) with AD-typical cerebral hypometabolic pattern compared with 27 cognitively healthy elderly individuals without preclinical AD. These findings yield further evidence for the potential of sAPP? in plasma as an AD biomarker candidate. «
The established biomarkers of Alzheimer's disease (AD) require invasive endeavours or presuppose sophisticated technical equipment. Consequently, new biomarkers are needed. Here, we report that plasma levels of soluble amyloid precursor protein ? (sAPP?), a protein of the initial phase of the amyloid cascade, were significantly lower in patients with symptomatic AD (21 with mild cognitive impairment due to AD and 44 with AD dementia) with AD-typical cerebral hypometabolic pattern compared with 2... »
Zeitschriftentitel:: Eur Arch Psychiatry Clin Neurosci
Jahr:: 2018
Band / Volume:: 268
Heft / Issue:: 5
Seitenangaben Beitrag:: 519-524
Sprache:: eng
Volltext / DOI:: doi:10.1007/s00406-017-0815-9
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/28602012
Print-ISSN:: 0940-1334
TUM Einrichtung:: Klinik für Anästhesiologie (DHM); Klinik und Poliklinik für Nuklearmedizin; Klinik und Poliklinik für Psychiatrie und Psychotherapie
BibTeX